The Upstream Bioprocessing market is a segment of the biotechnology industry that focuses on the production of biopharmaceuticals. This includes the development of processes and technologies for the production of biopharmaceuticals, such as cell culture, fermentation, and purification. Upstream bioprocessing is a critical step in the development of biopharmaceuticals, as it is responsible for the production of the active pharmaceutical ingredient (API). Upstream bioprocessing technologies are used to optimize the production of biopharmaceuticals, including the development of cell lines, media, and process conditions. These technologies are also used to improve the efficiency and cost-effectiveness of biopharmaceutical production. Some companies in the Upstream Bioprocessing market include Merck KGaA, Thermo Fisher Scientific, GE Healthcare, Lonza, and Sartorius AG. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.